| Revision as of 18:26, 9 January 2012 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Saving copy of the {{drugbox}} taken from revid 460516611 of page Suvizumab for the Chem/Drugbox validation project (updated: 'CAS_number'). |
Latest revision as of 19:04, 6 May 2024 edit Marbletan (talk | contribs)Extended confirmed users5,452 editsNo edit summary |
| Line 1: |
Line 1: |
|
|
{{Short description|Monoclonal antibody}} |
|
{{ambox | text = This page contains a copy of the infobox ({{tl|drugbox}}) taken from revid of page ] with values updated to verified values.}} |
|
|
{{Drugbox |
|
{{Drugbox |
|
| Verifiedfields = changed |
|
| Verifiedfields = changed |
|
| verifiedrevid = 450329548 |
|
| verifiedrevid = 470475254 |
|
| type = mab |
|
| type = mab |
|
| image = |
|
| image = |
| Line 9: |
Line 9: |
|
| source = zu |
|
| source = zu |
|
| target = ] |
|
| target = ] |
|
<!--Clinical data--> |
|
<!--Clinical data --> |
|
| tradename = |
|
| tradename = |
|
| Drugs.com = |
|
| Drugs.com = |
| Line 16: |
Line 16: |
|
| pregnancy_US = <!-- A / B / C / D / X --> |
|
| pregnancy_US = <!-- A / B / C / D / X --> |
|
| pregnancy_category= |
|
| pregnancy_category= |
|
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
|
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled --> |
|
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM --> |
|
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM --> |
| Line 22: |
Line 22: |
|
| legal_status = |
|
| legal_status = |
|
| routes_of_administration = |
|
| routes_of_administration = |
|
⚫ |
<!-- Pharmacokinetic data --> |
|
|
|
| ⚫ |
<!--Pharmacokinetic data--> |
|
|
| bioavailability = |
|
| bioavailability = |
|
| protein_bound = |
|
| protein_bound = |
| Line 29: |
Line 28: |
|
| elimination_half-life = |
|
| elimination_half-life = |
|
| excretion = |
|
| excretion = |
|
⚫ |
<!-- Identifiers --> |
|
|
|
| ⚫ |
<!--Identifiers--> |
|
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|
| ChemSpiderID = NA |
|
| ChemSpiderID = none |
|
| CAS_number_Ref = {{cascite|correct|??}} |
|
| CAS_number_Ref = {{cascite|changed|??}} |
|
| CAS_number = <!-- blanked - oldvalue: 1116433-11-4 --> |
|
| CAS_number = 914257-21-9 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
|
| UNII = 4AJ2TI6DPI |
|
| ATC_prefix = none |
|
| ATC_prefix = none |
|
| ATC_suffix = |
|
| ATC_suffix = |
| Line 40: |
Line 40: |
|
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|
| DrugBank = |
|
| DrugBank = |
|
⚫ |
<!-- Chemical data --> |
|
|
|
| ⚫ |
<!--Chemical data--> |
|
|
| chemical_formula = |
|
| chemical_formula = |
|
| molecular_weight = |
|
| molecular_weight = |
|
|
|
|
|
}} |
|
}} |
|
|
|
|
|
'''Suvizumab''' is an experimental ] and ]. It is a ] that binds to ].<ref>{{cite journal |title = Proposed List number 102 of International Nonproprietary Names|journal = WHO Drug Information|year = 2009|url =https://www.who.int/entity/medicines/publications/druginformation/innlists/PL_102.pdf|publisher = World Health Organization|location = Geneva|issn = 1010-9609|page = 344|volume = 23|issue = 4}}</ref> |
|
|
|
|
|
== References == |
|
|
<references/> |
|
|
|
|
|
{{monoclonals for infectious disease and toxins}} |
|
|
|
|
|
] |
|
|
] |
|
|
{{antiinfective-drug-stub}} |
|
|
{{monoclonal-antibody-stub}} |